Frequently Asked Questions on the Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19

Frequently Asked Questions on the Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19

SABCS

2 months
8 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Gerardo Antonio Umanzor, MD of Liga Contra el Cáncer answers frequently asked questions on paclitaxel shown to be superior to IV paclitaxel: a Phase III clinical study in metastatic breast cancer.
Up Next Autoplay